Somerville Kurt F Purchases Shares of 45,245 Danaher Corporation $DHR

Key Points

• Somerville Kurt F purchased 45,245 Danaher shares worth approximately $8.6 million, making DHR its 19th-largest holding and representing 2.1% of its portfolio.
• Institutional ownership remains substantial at 79.05%, with major investors including BlackRock, Norges Bank, Generation Investment Management, Flossbach von Storch and Bank of New York Mellon adding positions.
• Danaher reported quarterly EPS of $1.94 and revenue of $6.26 billion, exceeding analyst estimates, while analysts maintain a “Moderate Buy” consensus with an average price target of $228.91.

Somerville Kurt F bought a new stake in shares of Danaher Corporation (NYSE:DHR - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 45,245 shares of the conglomerate's stock, valued at approximately $8,618,000. Danaher accounts for approximately 2.1% of Somerville Kurt F's investment portfolio, making the stock its 19th biggest position.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. BlackRock Inc. bought a new position in shares of Danaher during the second quarter worth $10,492,520,000. Norges Bank bought a new stake in Danaher in the 4th quarter valued at $2,177,106,000. Generation Investment Management LLP purchased a new stake in Danaher in the 2nd quarter worth $1,287,949,000. Flossbach Von Storch SE purchased a new stake in Danaher in the 2nd quarter worth $747,260,000. Finally, Bank of New York Mellon Corp bought a new position in shares of Danaher during the 2nd quarter valued at about $712,875,000. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on DHR shares. Argus reduced their target price on Danaher from $265.00 to $230.00 and set a "buy" rating on the stock in a report on Friday, April 24th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. Weiss Ratings raised Danaher from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Wednesday, July 15th. Wells Fargo & Company decreased their price objective on Danaher from $212.00 to $195.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 22nd. Finally, HSBC cut their target price on shares of Danaher from $270.00 to $230.00 and set a "buy" rating for the company in a report on Wednesday, June 3rd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $228.91.

Danaher Trading Up 2.2%

Shares of DHR stock opened at $216.14 on Friday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The stock's 50 day simple moving average is $195.01 and its two-hundred day simple moving average is $192.43. The company has a market cap of $151.94 billion, a PE ratio of 38.39, a price-to-earnings-growth ratio of 2.63 and a beta of 0.78.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts' consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analysts' expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The company's quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.77 EPS. Research analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source